Prospects for potassium channel activators in the treatment of airways obstruction.
Buckle
D R
DR
SmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK.
D000402:Airway Obstruction / Q000188:drug therapy*; D000818:Animals; D001578:Benzopyrans; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D019806:Cromakalim; D006801:Humans; D009126:Muscle Relaxation / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects*; D011758:Pyrroles; D014132:Trachea / Q000187:drug effects
D001578:Benzopyrans; D001993:Bronchodilator Agents; D015221:Potassium Channels; D011758:Pyrroles; D019806:Cromakalim